Cargando…
Intravitreal methotrexate and fluocinolone acetonide implantation for Vogt-Koyanagi-Harada uveitis
PURPOSE: To report a case of intravitreal methotrexate treatment and fluocinolone acetonide (Retisert®) implantation in a patient with Vogt-Koyanagi-Harada syndrome (VKH). OBSERVATIONS: A 34-year-old male was referred for worsening vision and bilateral panuveitis consistent with VKH. He was treated...
Autores principales: | Park, Jong G., Callaway, Natalia F., Ludwig, Cassie A., Mahajan, Vinit B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415829/ https://www.ncbi.nlm.nih.gov/pubmed/32793845 http://dx.doi.org/10.1016/j.ajoc.2020.100859 |
Ejemplares similares
-
Commentary: Dexamethasone intravitreal implant therapy in Vogt–Koyanagi–Harada disease
por: Kawali, Ankush, et al.
Publicado: (2022) -
Long-term efficacy of dexamethasone intravitreal implant in the treatment of Vogt-Koyanagi-Harada disease relapsing posterior uveitis
por: Elhamaky, Tarek R
Publicado: (2022) -
Commentary: Appraisal of histopathological correlations in Vogt-Koyanagi-Harada uveitis
por: Murugan, Sivaraman Bala
Publicado: (2019) -
Intravitreal triamcinolone acetonide for rebound phenomenon after high-dose intravenous steroid treatment in Vogt-Koyanagi-Harada disease
por: Byon, Ik Soo, et al.
Publicado: (2011) -
Tuberculous Posterior Sclero-Uveitis with Features of Vogt-Koyanagi-Harada Uveitis: An Unusual Case
por: Kalogeropoulos, Dimitrios, et al.
Publicado: (2017)